問卷

TPIDB > Principal Investigator

Principal Investigator


Hualien Tzu Chi Hospital

Division of Cardiovascular Diseases

更新時間:2025-08-20

張元傑
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

4Cases

2024-09-01 - 2028-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
14Sites

Recruiting14Sites

2025-03-01 - 2030-06-30

Phase III

Active
A Phase III, Randomised, Placebo-controlled, Event-driven Study to Evaluate the Effect of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on the Risk of Incident Heart Failure and Cardiovascular Death
  • Condition/Disease

    To reduce the risk of heart failure events and cardiovascular (CV) death in patients at high risk for developing heart failure.

  • Test Drug

    Baxdrostat Dapagliflozin

Participate Sites
18Sites

Recruiting18Sites

2026-03-01 - 2030-10-09

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Not yet recruiting9Sites

2026-01-01 - 2031-09-18

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
15Sites